K Hamada

MedicineAgricultural and Biological SciencesEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations”.

A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations

Investigational New Drugs(2021)10.1007/s10637-021-01104-7

N/A

0.452DataRank · unranked

6 citations

Analía Azaro, Hendrik Tobias Arkenau, Do‐Youn Oh, Matthew D. Galsky, Sumanta K. Pal +6 more